Marker Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

MRKR

organization

SIC: 2834

SEC Insider

$125.1M

201 transactions

Summary

Marker Therapeutics, Inc. (MRKR) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $111.5MSales: $19K39 insiders

Date	Insider	Type	Value
2024-12-23	Joint reporting: SANDELL SCOTT D; BASKETT FOREST; Walker Paul Edward; Florence Anthony A. Jr.; Behbahani Ali; Makhzoumi Mohamad; New Enterprise Associates 16, L.P.; NEA Partners 16, L.P.; NEA 16 GP, LLC; Chang Carmen	Buy	$1.8M
2024-12-23	ELMS STEVE	Buy	$35K
2025-11-17	ELMS STEVE	A	$0
2025-11-17	ELMS STEVE	A	$0
2025-11-17	Eansor Norman David	A	$0
2025-11-17	Eansor Norman David	A	$0
2025-11-17	Knobil Katharine	A	$0
2025-11-17	Knobil Katharine	A	$0
2025-10-31	Vera Juan(Chief Executive Officer)	A	$0
2025-10-31	Corzo Kathryn Penkus	A	$0
2025-02-12	Vera Juan(President and CEO)	A	$0
2025-02-12	Eansor Norman David	A	$0
2025-02-12	Knobil Katharine	A	$0
2025-02-12	ELMS STEVE	A	$0
2023-06-06	ELMS STEVE	A	$0
2023-06-06	Wilson John Robert	A	$0
2023-06-06	Knobil Katharine	A	$0
2023-06-06	Eansor Norman David	A	$0
2023-05-10	Vera Juan(President and CEO)	A	$0
2023-02-27	Agopyan Nadia(SVP, Regulatory Affairs)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Marker Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope